Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Thomas Lingelbach
Person

Thomas Lingelbach

Tracked across 1 events · 12 articles · First seen Aug 14, 2026 · Last active Aug 17, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Regulatory
EMA validates Pfizer-Valneva Lyme vaccine application
The European Union — European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, a 6-valent OspA-based Lyme disease vaccine candidate co-developed by Pfizer and Valneva SE. The validation allows the EMA…
Impact: CEO of Valneva, quoted highlighting the milestone and the large at-risk population in Europe.
Aug 14, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Thomas Lingelbach live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.